Review series - inflammation & fibrosis: Fibrocytes and fibrosis

QJM: An International Journal of Medicine

Volumn 105, Issue 6, 2012, Pages 505-508

  Bucala, R ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; B7 ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; CHEMOKINE; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR4; COLLAGEN TYPE 1; CYTOKINE; ENDOTHELIN 1; GAMMA INTERFERON; GROWTH FACTOR; INTERLEUKIN 2; INTERLEUKIN 4; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; SCLEROPROTEIN; SERUM AMYLOID P; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ASTHMA; ATHEROSCLEROSIS; CANCER INVASION; CELL DIFFERENTIATION; CELL MIGRATION; DENDRITIC CELL; DISEASE COURSE; DOWN REGULATION; ENDOCRINE OPHTHALMOPATHY; ENDOTHELIUM CELL; EPITHELIUM CELL; FIBROBLAST; FIBROGENESIS; FIBROSING ALVEOLITIS; FLOW CYTOMETRY; GRANULOMA; HUMAN; HYPERTROPHIC SCAR; IMMUNE RESPONSE; IN VITRO STUDY; INFLAMMATION; INJURY; INTERSTITIAL LUNG DISEASE; INTERSTITIAL PNEUMONIA; KELOID; KIDNEY FIBROSIS; LANGERHANS CELL; LUNG FIBROSIS; LUNG FUNCTION; MICROVILLUS; MONOCYTE; MYOFIBROBLAST; NEPHROGENIC SYSTEMIC FIBROSIS; NONHUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOPODIUM; REVIEW; SAP FLOW; SCANNING ELECTRON MICROSCOPY; SCLERODERMA; SPINDLE CELL; SUBCUTANEOUS TISSUE; T LYMPHOCYTE; TISSUE REPAIR; WOUND CONTRACTION; WOUND HEALING;

EID: 84861750214     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcs068     Document Type: Review

References (26)

1. Bucala R, Spiegel L, Chesney J, Hogan M, Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med, 1: 1994, 71-81.
2. Bellini A, Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest, 87: 2007, 858-70.
3. Herzog EL, Bucala R. Fibrocytes in health and disease. Exp Hematol, 38: 2010, 548-56.
4. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol, 166: 2001, 7556-62.
5. Moore BB, Kolodsick JE, Thannickal VJ, Cooke K, Moore TA, Hogaboam C, et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol, 166: 2005, 675-84.
6. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest, 114: 2004, 438-46.
7. Hashimoto N, Jin H, Liu TJ, Chensue SW, Phan SH. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest, 113: 2004, 243-52.
8. Aiba S, Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol, 24: 1997, 65-9.
9. Mori L, Bellini A, Stacey MA, Schmidt M, Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res, 304: 2005, 81-90.
10. Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol, 171: 2003, 380-9.
11. Chesney J, Bacher M, Bender A, Bucala R. The peripheral blood fibrocyte is a potent antigen-presenting cell capable of priming naive T-cells in situ. Proc Natl Acad Sci USA, 94: 1997, 6307-12.
12. Balmelli C, Ruggli N, McCullough K, Summerfield A. Fibrocytes are potent stimulators of anti-virus cytotoxic T cells. J Leukoc Biol, 77: 2005, 923-33.
13. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D. Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol, 83: 2008, 1323-33.
14. Chesney J, Metz C, Stavitsky A, Bacher M, Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol, 160: 1998, 419-25.
15. Pilling D, Buckley CD, Salmon M, Gomer RH. Inhibition of fibrocyte differentiation by serum amyloid P. J Immunol, 171: 2003, 5537-46.
16. Pilling D, Tucker NM, Gomer RH. Aggregated IgG inhibits the differentiation of human fibrocytes. J Leukoc Biol, 79: 2006, 1242-51.
17. Wang JF, Jiao HY, Stewart TL, Shankowsky HA, Scott PG, Tredget EE. Increased severity of bleomycin-induced skin fibrosis in mice with leukocyte-specific protein 1 deficiency. J Investig Dermatol, 128: 2008, 2767-76.
18. Chan ESL, Fernandez P, Merchant AA, Desai A, Montesinos MC, Tung CF, et al. Adenosine A(2A) receptors and dermal fibrosis: a pathogenic role for adenosine in diffuse dermal fibrosis. J Investig Dermatol Symp Proc 2006; 11:144.
19. Gomer RH, Lupher ML. Investigational approaches to therapies for idiopathic pulmonary fibrosis. Expert Opin Investig Drugs, 19: 2010, 737-45.
20. Naik-Mathuris B, Pilling D, Crawford JR, Gay AN, Smith CW, Gomer RH, et al. Serum amyloid P inhibits dermal wound healing. Wound Repair Regen, 16: 2008, 266-73.
21. Mehrad B, Burdick MD, Zisman DA, Keane MP, Belperio JA, Strieter RM. Circulating peripheral blood fibrocytes in human fibrotic interstitial lung disease. Biochem Biophys Res Commun, 353: 2007, 104-8.
22. Moeller A, Gilpin SE, Ask K, Cox G, Cook D, Gauldie J, et al. Circulating fibrocytes are an indicator of poor prognosis in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med, 179: 2009, 588-94.
23. Mathai SK, Gulati M, Peng XY, Russell TR, Shaw AC, Rubinowitz AN, et al. Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype. Lab Invest, 90: 2010, 812-23.
24. Niedermeier M, Reich B, Gomez MR, Denzel A, Schmidbauer K, Gobel N, et al. CD4(+) T cells control the differentiation of Gr1(+) monocytes into fibrocytes. Proc Natl Acad Sci USA, 106: 2009, 17892-7.
25. Vannella KM, McMillan TR, Charbeneau RP, Wilke CA, Thomas PE, Toews GB, et al. Cysteinyl leukotrienes are autocrine and paracrine regulators of fibrocyte function. J Immunol, 179: 2007, 7883-90.
26. Maharjan A, Pilling D, Gomer RH. Toll-like receptor 2 agonists inhibit human fibrocyte differentiation. Fibrogenesis Tissue Repair 2010; 3:23.